These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 29649502

  • 1. A behavioral mechanistic investigation of the role of 5-HT1A receptors in the mediation of rat maternal behavior.
    Li X, Ding X, Wu R, Chen L, Gao J, Hu G, Li M.
    Pharmacol Biochem Behav; 2018 Jun; 169():16-26. PubMed ID: 29649502
    [Abstract] [Full Text] [Related]

  • 2. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M, Samanin R.
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [Abstract] [Full Text] [Related]

  • 3. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH.
    Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
    [Abstract] [Full Text] [Related]

  • 4. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
    Bardin L, Tarayre JP, Koek W, Colpaert FC.
    Eur J Pharmacol; 2001 Jun 08; 421(2):109-14. PubMed ID: 11399266
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 9. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.
    Egashira N, Yano A, Ishigami N, Mishima K, Iwasaki K, Fujioka M, Matsushita M, Nishimura R, Fujiwara M.
    Brain Res; 2006 Jan 19; 1069(1):54-62. PubMed ID: 16386718
    [Abstract] [Full Text] [Related]

  • 10. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation.
    Gogos A, Kusljic S, van den Buuse M.
    Pharmacol Biochem Behav; 2005 Jul 19; 81(3):664-72. PubMed ID: 15955549
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep 19; 181(2):381-91. PubMed ID: 15830225
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 19; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 13. 8-OH-DPAT enhances dopamine D2-induced maternal disruption in rats.
    Cai Y, Zhang X, Jiang T, Zhong H, Han X, Ma R, Wu R.
    J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2022 Jul 19; 208(4):467-477. PubMed ID: 35434766
    [Abstract] [Full Text] [Related]

  • 14. Activation of septal 5-HT1A receptors alters spatial memory encoding, interferes with consolidation, but does not affect retrieval in rats subjected to a water-maze task.
    Koenig J, Cosquer B, Cassel JC.
    Hippocampus; 2008 Jul 19; 18(1):99-118. PubMed ID: 17924524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 5-HT1A receptor agonist and antagonist on anxiety in intact and ovariectomized female rats.
    Fedotova JO, Hartmann G, Lénárd L, Sapronov NS.
    Acta Physiol Hung; 2004 Jul 19; 91(3-4):175-84. PubMed ID: 16438111
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct 19; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

  • 19. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
    Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.
    Neuropsychopharmacology; 2006 Feb 19; 31(2):247-55. PubMed ID: 16012533
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 19; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.